These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7590855)

  • 1. Glycoside-bearing liposomal delivery systems against macrophage-associated disorders involving Mycobacterium leprae and Mycobacterium tuberculosis.
    Medda S; Das N; Mahato SB; Mahadevan PR; Basu MK
    Indian J Biochem Biophys; 1995 Jun; 32(3):147-51. PubMed ID: 7590855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of plant glycoside-bearing liposomes to specific cellular and subcellular sites.
    Medda S; Das N; Bachhawat BK; Mahato SB; Basu MK
    Biotechnol Appl Biochem; 1990 Oct; 12(5):537-43. PubMed ID: 2288709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-based drug delivery to alveolar macrophages.
    Vyas SP; Khatri K
    Expert Opin Drug Deliv; 2007 Mar; 4(2):95-9. PubMed ID: 17335407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections.
    Gupta CM; Haq W
    Methods Enzymol; 2005; 391():291-304. PubMed ID: 15721387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid differentiation of Mycobacterium tuberculosis and Mycobacterium leprae from sputum by polymerase chain reaction.
    Sapkota BR; Ranjit C; Macdonald M
    Nepal Med Coll J; 2007 Mar; 9(1):12-6. PubMed ID: 17593671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis.
    El-Ridy MS; Mostafa DM; Shehab A; Nasr EA; Abd El-Alim S
    Int J Pharm; 2007 Feb; 330(1-2):82-8. PubMed ID: 17049192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.
    de Steenwinkel JE; van Vianen W; Ten Kate MT; Verbrugh HA; van Agtmael MA; Schiffelers RM; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Nov; 60(5):1064-73. PubMed ID: 17846106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the phenomenon of persistence in mycobacterial infections.
    Gupta UD; Katoch VM
    Indian J Lepr; 1997; 69(4):385-93. PubMed ID: 9474514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
    Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
    J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitrouptake and antimycobacterial activity of liposomal usnic acid formulation.
    Lira MC; Siqueira-Moura MP; Rolim-Santos HM; Galetti FC; Simioni AR; Santos NP; Tabosa Do Egito ES; Silva CL; Tedesco AC; Santos-Magalhães NS
    J Liposome Res; 2009; 19(1):49-58. PubMed ID: 19515007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of a liposomal form of rifampicin in the treatment of experimental tuberculosis in mice].
    Kurunov IuN; Kaledin VI; Popova NA; Panteleeva AG
    Probl Tuberk; 1992; (1-2):13-5. PubMed ID: 1603780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro experiments with Centella asiatica: investigation to elucidate the effect of an indigenously prepared powder of this plant on the acid-fastness and viability of M. tuberculosis.
    Herbert D; Paramasivan CN; Prabhakar R; Swaminathan G
    Indian J Lepr; 1994; 66(1):65-8. PubMed ID: 7983394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.
    Khan MA; Nasti TH; Owais M
    J Antimicrob Chemother; 2005 Oct; 56(4):726-31. PubMed ID: 16126780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors.
    Mayer LD; Dougherty G; Harasym TO; Bally MB
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1406-14. PubMed ID: 9067330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effect of delipidified cell component of Mycobacterium leprae in relation to infection with leprosy bacteria in mice.
    Damle A; Mahadevan PR
    Indian J Lepr; 1993; 65(3):271-82. PubMed ID: 8283062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.